CLINICAL_TRIALS
withdrawal
· 2013-02-01
Clinical Trial Update: Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy [NA]
Summary
A Roswell Park Cancer Institute study evaluating a combination of ketoconazole, dexamethasone, and hydrocortisone for patients with prostate cancer that did not…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Cancer | NA | Status: WITHDRAWN